An observational study in Cirrhosis, Liver, sponsored by SUUMC Central Military Hospital Dr Carol Davila. Recruiting at 1 site in Romania. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-12-19.
Sponsored by SUUMC Central Military Hospital Dr Carol Davila · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Liver Cirrhosis with a site in Romania — 6 open to participants now, 6 under way, 1 of them phase 3. Liver Cirrhosis · Romania.
Among the 22 studies in Liver Cirrhosis with a site in Romania, this one is one of 4 that started in 2023, is one of 6 observational ones, and was the 14th registered.
1,303 studies on the registry are indexed under Liver Cirrhosis; 341 are open to participants now.
Browse Liver Cirrhosis studies →6 of the 22 studies in Liver Cirrhosis with a site in Romania are open now. Recruiting first, the newest first:
University Medical Center Groningen · Sites in Romania, Austria, Belgium and 9 more countries
Ages 18+
Grigore T. Popa University of Medicine and Pharmacy · Sites in Romania
Ages 18+
Boehringer Ingelheim · Sites in Romania, United States, Argentina and 34 more countries
Ages 18+
Carol Davila University of Medicine and Pharmacy · Sites in Romania
Ages 18+
Julius Clinical · Sites in Romania, Belgium, Czechia and 7 more countries
Ages 18–75
A study can be open while its sites in Romania have not opened yet or have stopped. Only those recruiting at a site in Romania →
Of the 208 Liver Cirrhosis studies recruiting now, 101 (49%) set no upper age limit and 66 (32%) stop at 75 or younger; 12 take children under 18; 25 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 172 across 528 observational studies indexed under Liver Cirrhosis.
Median enrollment 223 across the 16 interventional studies, 1,417 across the 6 observational. Of the 15 that completed or were terminated, 6 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 22 have an industry lead sponsor. The 10 most frequent:
SUUMC Central Military Hospital Dr Carol Davila is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
SUUMC Central Military Hospital Dr Carol Davila has 1 study filed under Liver Cirrhosis — fewer than ten, so there is no comparison to draw.
1 of the studies in Liver Cirrhosis with a site in Romania that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07585890University Medical Center GroningenEstablishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Liver Cirrhosis with a site in Romania, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluated nutritional status in patiets with cirrhosis
patients males and females with hepatic cirrhosis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
status of nutrition evaluation after 3 months of BCAA
Also known as: branched chain amino acids
muscle mass change
muscle mass changes in DEXA or body composition measurement
Time frame: 3 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2023 (actual). Primary completion is estimated for Dec 2025, 35 months after the start.
Of 231 non-industry observational studies under Liver Cirrhosis, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 35 months is below that.
Counting every sponsor, half of 247 studies reached it within 47 months; a quarter within 18 and three quarters within 71.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SUUMC Central Military Hospital Dr Carol Davila